(Q82423420)
Statements
The cost-effectiveness of saxagliptin versus NPH insulin when used in combination with other oral antidiabetes agents in the treatment of type 2 diabetes mellitus in Poland (English)
Leszek Czupryniak
Katarzyna Kolasa
Cezary Sciborski
Isabelle Duprat Lomon